NASDAQ: AAPG
Ascentage Pharma Group International Stock Forecast, Predictions & Price Target

Analyst price target for AAPG

Based on 4 analysts offering 12 month price targets for Ascentage Pharma Group International

Min Forecast
$45.00+77.87%
Avg Forecast
$48.50+91.7%
Max Forecast
$51.00+101.58%

Should I buy or sell AAPG stock?

Based on 4 analysts offering ratings for Ascentage Pharma Group International.

Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AAPG stock forecasts and price targets.

AAPG stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-04
lockedlocked$00.00+00.00%2025-11-24
lockedlocked$00.00+00.00%2025-11-10
lockedlocked$00.00+00.00%2025-11-05

1 of 1

Forecast return on equity

Is AAPG forecast to generate an efficient return?

Company
-2,170.47%
Industry
355.57%
Market
202.3%
AAPG's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AAPG forecast to generate an efficient return on assets?

Company
-476.09%
Industry
123.33%
AAPG is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AAPG earnings per share forecast

What is AAPG's earnings per share in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$2.37
Avg 2 year Forecast
-$0.76
Avg 3 year Forecast
-$5.77

AAPG revenue forecast

What is AAPG's revenue in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$2.8B+5,059.6%
Avg 2 year Forecast
$1.9B+3,321.94%
Avg 3 year Forecast
$2.1B+3,690.09%
AAPG's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AAPG revenue growth forecast

How is AAPG forecast to perform vs Biotechnology companies and vs the US market?

Company
235.75%
Industry
116.52%
Market
23.59%
AAPG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AAPG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AAPG vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AAPG$25.30$48.50+91.70%Strong Buy
OCUL$10.28$23.25+126.17%Strong Buy
SRPT$21.31$22.71+6.55%Hold
SLNO$41.60$105.00+152.40%Strong Buy
GLPG$34.10$36.00+5.57%Buy

Ascentage Pharma Group International Stock Forecast FAQ

Is Ascentage Pharma Group International Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: AAPG) stock is to Strong Buy AAPG stock.

Out of 4 analysts, 3 (75%) are recommending AAPG as a Strong Buy, 1 (25%) are recommending AAPG as a Buy, 0 (0%) are recommending AAPG as a Hold, 0 (0%) are recommending AAPG as a Sell, and 0 (0%) are recommending AAPG as a Strong Sell.

If you're new to stock investing, here's how to buy Ascentage Pharma Group International stock.

What is AAPG's earnings growth forecast for 2026-2029?

(NASDAQ: AAPG) Ascentage Pharma Group International's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 70.53%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.49%.

Ascentage Pharma Group International's earnings in 2026 is -$161,448,746.On average, 10 Wall Street analysts forecast AAPG's earnings for 2026 to be $828,105,586, with the lowest AAPG earnings forecast at -$277,035,660, and the highest AAPG earnings forecast at $1,689,331,208. On average, 8 Wall Street analysts forecast AAPG's earnings for 2027 to be -$264,332,085, with the lowest AAPG earnings forecast at -$820,846,401, and the highest AAPG earnings forecast at $1,201,953,658.

In 2029, AAPG is forecast to generate -$2,013,272,377 in earnings, with the lowest earnings forecast at -$1,934,328,731 and the highest earnings forecast at -$2,072,497,562.

What is AAPG's revenue growth forecast for 2026-2028?

(NASDAQ: AAPG) Ascentage Pharma Group International's forecast annual revenue growth rate of 235.75% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 116.52%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.59%.

Ascentage Pharma Group International's revenue in 2026 is $54,401,532.On average, 10 Wall Street analysts forecast AAPG's revenue for 2026 to be $978,245,093,960, with the lowest AAPG revenue forecast at $624,010,784,160, and the highest AAPG revenue forecast at $1,196,718,668,280. On average, 10 Wall Street analysts forecast AAPG's revenue for 2027 to be $648,789,735,880, with the lowest AAPG revenue forecast at $352,140,313,880, and the highest AAPG revenue forecast at $1,107,025,843,040.

In 2028, AAPG is forecast to generate $718,589,599,880 in revenue, with the lowest revenue forecast at $413,564,194,200 and the highest revenue forecast at $886,458,272,800.

What is AAPG's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: AAPG) forecast ROA is -476.09%, which is lower than the forecast US Biotechnology industry average of 123.33%.

What is AAPG's Price Target?

According to 4 Wall Street analysts that have issued a 1 year AAPG price target, the average AAPG price target is $48.50, with the highest AAPG stock price forecast at $51.00 and the lowest AAPG stock price forecast at $45.00.

On average, Wall Street analysts predict that Ascentage Pharma Group International's share price could reach $48.50 by Dec 4, 2026. The average Ascentage Pharma Group International stock price prediction forecasts a potential upside of 91.7% from the current AAPG share price of $25.30.

What is AAPG's Earnings Per Share (EPS) forecast for 2026-2029?

(NASDAQ: AAPG) Ascentage Pharma Group International's current Earnings Per Share (EPS) is -$2.02. On average, analysts forecast that AAPG's EPS will be $2.37 for 2026, with the lowest EPS forecast at -$0.79, and the highest EPS forecast at $4.84. On average, analysts forecast that AAPG's EPS will be -$0.76 for 2027, with the lowest EPS forecast at -$2.35, and the highest EPS forecast at $3.44. In 2029, AAPG's EPS is forecast to hit -$5.77 (min: -$5.54, max: -$5.94).

What is AAPG's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: AAPG) forecast ROE is -2,170.47%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.